Source:http://linkedlifedata.com/resource/pubmed/id/14726631
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2004-2-18
|
pubmed:abstractText |
In skeletal muscle, insulin increases glucose uptake through endothelium-derived nitric oxide (EDNO)-dependent vasodilation. Insulin also enhances myocardial glucose uptake, but it is unknown whether vasodilation participates in the underlying mechanism. We studied whether insulin-stimulated myocardial glucose uptake (MGU) is associated with perfusion changes and whether MGU is EDNO dependent. Myocardial perfusion (MBF) and MGU were measured three times with positron emission tomography in 8 healthy volunteers (56 +/- 6 years): (1). During a hyperinsulinemic euglycemic clamp (clamp), (2). during clamp and blockage of the nitric oxide synthesis by L-NMMA and (3). during clamp and nitric oxide stimulation with nitroglycerin. We measured MBF at rest before and during clamp utilizing (13)N-ammonia and (18)F-fluoro-deoxy-glucose as perfusion and glucose tracers, respectively. Hemodynamics were affected neither by insulin nor by L-NMMA. Nitroglycerin reduced rate-pressure product. Insulin did not affect MBF. L-NMMA reduced MBF (0.60 +/- 0.15 vs. 0.66 +/- 0.14 ml/g/min; p < 0.05), while MGU was unchanged. Nitroglycerin did not alter MBF, while MGU was reduced (0.44 +/- 0.11 vs. 0.52 +/- 0.13 micromol/g/min; p = 0.05). Insulin-stimulated MGU does not rely on a simultaneous increment of MBF. Myocardial glucose uptake can be stimulated even when MBF decreases, suggesting that autoregulation of MGU is preserved despite uncoupling of vascular autoregulation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide,
http://linkedlifedata.com/resource/pubmed/chemical/Nitroglycerin,
http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents,
http://linkedlifedata.com/resource/pubmed/chemical/omega-N-Methylarginine
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1018-1172
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2004 S. Karger AG, Basel
|
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
38-45
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:14726631-Aged,
pubmed-meshheading:14726631-Blood Glucose,
pubmed-meshheading:14726631-Blood Pressure,
pubmed-meshheading:14726631-Coronary Circulation,
pubmed-meshheading:14726631-Energy Metabolism,
pubmed-meshheading:14726631-Enzyme Inhibitors,
pubmed-meshheading:14726631-Heart Rate,
pubmed-meshheading:14726631-Humans,
pubmed-meshheading:14726631-Hyperinsulinism,
pubmed-meshheading:14726631-Hypoglycemic Agents,
pubmed-meshheading:14726631-Insulin,
pubmed-meshheading:14726631-Male,
pubmed-meshheading:14726631-Middle Aged,
pubmed-meshheading:14726631-Myocardium,
pubmed-meshheading:14726631-Nitric Oxide,
pubmed-meshheading:14726631-Nitroglycerin,
pubmed-meshheading:14726631-Vasodilator Agents,
pubmed-meshheading:14726631-omega-N-Methylarginine
|
pubmed:articleTitle |
Insulin-stimulated myocardial glucose uptake and the relation to perfusion and the nitric oxide system.
|
pubmed:affiliation |
Department of Cardiology B, Aarhus University Hospital (SKS), Aarhus, Denmark.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|